6-33293230-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_004761.5(RGL2):​c.1793C>T​(p.Pro598Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00106 in 1,559,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

Frequency

Genomes: 𝑓 0.00051 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 0 hom. )

Consequence

RGL2
NM_004761.5 missense

Scores

6
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.76
Variant links:
Genes affected
RGL2 (HGNC:9769): (ral guanine nucleotide dissociation stimulator like 2) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of catalytic activity and small GTPase mediated signal transduction. Predicted to act upstream of or within negative regulation of cardiac muscle cell apoptotic process; positive regulation of phosphatidylinositol 3-kinase signaling; and regulation of Ral protein signal transduction. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
PFDN6 (HGNC:4926): (prefoldin subunit 6) PFDN6 is a subunit of the heteromeric prefoldin complex that chaperones nascent actin (see MIM 102560) and alpha- and beta-tubulin (see MIM 602529 and MIM 191130, respectively) chains pending their transfer to the cytosolic chaperonin containing TCP1 (MIM 186980) (CCT) complex (Hansen et al., 1999 [PubMed 10209023]).[supplied by OMIM, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.040563107).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RGL2NM_004761.5 linkuse as main transcriptc.1793C>T p.Pro598Leu missense_variant 16/18 ENST00000497454.6 NP_004752.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RGL2ENST00000497454.6 linkuse as main transcriptc.1793C>T p.Pro598Leu missense_variant 16/181 NM_004761.5 ENSP00000420211 P1O15211-1

Frequencies

GnomAD3 genomes
AF:
0.000512
AC:
78
AN:
152258
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00101
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000570
AC:
112
AN:
196354
Hom.:
0
AF XY:
0.000556
AC XY:
58
AN XY:
104246
show subpopulations
Gnomad AFR exome
AF:
0.000128
Gnomad AMR exome
AF:
0.000190
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000574
Gnomad NFE exome
AF:
0.00113
Gnomad OTH exome
AF:
0.000218
GnomAD4 exome
AF:
0.00112
AC:
1576
AN:
1407008
Hom.:
0
Cov.:
33
AF XY:
0.00107
AC XY:
747
AN XY:
695358
show subpopulations
Gnomad4 AFR exome
AF:
0.000126
Gnomad4 AMR exome
AF:
0.000138
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000218
Gnomad4 NFE exome
AF:
0.00136
Gnomad4 OTH exome
AF:
0.00121
GnomAD4 genome
AF:
0.000512
AC:
78
AN:
152376
Hom.:
0
Cov.:
32
AF XY:
0.000429
AC XY:
32
AN XY:
74522
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00101
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000922
Hom.:
0
Bravo
AF:
0.000586
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.000612
AC:
74

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 08, 2022The c.1793C>T (p.P598L) alteration is located in exon 16 (coding exon 15) of the RGL2 gene. This alteration results from a C to T substitution at nucleotide position 1793, causing the proline (P) at amino acid position 598 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.38
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.035
T
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Uncertain
0.89
D
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.041
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-2.7
D
REVEL
Benign
0.076
Sift
Uncertain
0.0030
D
Sift4G
Benign
0.14
T
Polyphen
0.76
P
Vest4
0.26
MVP
0.59
MPC
0.36
ClinPred
0.11
T
GERP RS
4.5
Varity_R
0.12
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34022110; hg19: chr6-33261007; API